Login / Signup

Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective.

Pierre LevyTobiasz LemańskiCatriona CrossanAnna LefebvreJean-Baptiste BrièreLuca Degli EspostiZeba M Khan
Published in: Expert review of pharmacoeconomics & outcomes research (2024)
The findings indicate that a perindopril/amlodipine/indapamide SPC is a cost-saving treatment option for hypertension in Italy, compared to its FEC.
Keyphrases
  • hypertensive patients
  • blood pressure
  • arterial hypertension
  • quality improvement
  • combination therapy
  • replacement therapy
  • data analysis